Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA’s $240K Investment Targets Gene Replacement Therapy in CMT4 Subtypes
…the Strategy to Accelerate Research (STAR) initiative, CMTA has been at the forefront of accelerating gene replacement therapies for CMT, underscoring our leadership in this critical area of research,” said…
CMTAWinter2021Report
www.cmtausa.org WINTER 2021/2022 CMTATHE REPORT Research Grants and Collaborations Footcare for CMTers Applying for SSDI6 14 17> > > C O N TE N TS WINTER 2021/2022 RESEARCH NEW RESEARCH…
CMTA Announces Strategic Partnership with Acceleron to Advance CMT Treatment Options
…developing medicines to treat serious and rare diseases, including CMT. The CMTA’s Strategy to Accelerate Research (STAR) connects top CMT clinicians and academic researchers with pharmaceutical partners committed to developing…
For Researchers & Industry
CMTA’s $450K Investment Targets New Approach to Treatment for Patients with CMT1A and CMT1B
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth (CMT) disease research aimed at bringing treatments to patients, announced today an investment of $450K into a new scientific approach…
CMTA Adds Drug Development Expert Martine Garnier to STAR Advisory Board
…disease. It does so with an aggressive, multipronged attack, bringing together a group of top-flight researchers and experts and directly funding their work. CMTA launched its Strategy to Accelerate Research,…
CMT Awareness Month 2023
…color print. Check out the Sky of Fame. Register for the 2023 Patient & Research Summit The 2023 CMTA Patient & Research Summit on Saturday, November 4th will offer life-improving…
Seattle Focus Group with Acceleron Pharma
We are pleased to announce another opportunity to get involved with the CMTA’s Patients as Partners in Research initiative! The goal of Patients as Partners in Research is to advance…
CMTA and ToolGen Announce CMT1A Collaboration
…CMTA has been able to establish research partnerships with almost 40 pharmaceutical and biotech companies, and leading research labs around the world.” The testing alliance with ToolGen involves access to…
The_2018_CMTA_Report_35th_Anniversary_Edition
…picture of how prevalent CMT actually is. • Influences and perhaps changes the direction CMT research will take. • Stimulates research interest and attracts more research funds. • Speeds up…